Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized TD-4208 in COPD
NCT02459080Phase 3Completed
- Sponsor
- Mylan
- Start
- Sep 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of revefenacin in chronic obstructive pulmonary disease (COPD), sponsored by Mylan. Started Sep 2015; status: completed.
02
Drugs
revefenacin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02459080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02459080.